Cargando…

MCT4 is an important determinant for the growth of highly glycolytic and aggressive malignancies

Detalles Bibliográficos
Autores principales:	Unsal-Kacmaz, Kezi, Ragunathan, Shoba, Shan, Jennifer, Guo, Bing, Wang, Xiaoli, Tkach, Diane, Lucas, Judy, Klippel, Anke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374212/ http://dx.doi.org/10.1186/1753-6561-6-S3-O26

Ejemplares similares

Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2016)

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
por: Birsoy, Kivanc, et al.
Publicado: (2012)

Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors
por: Falk, Matthew D., et al.
Publicado: (2014)

MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
por: Zhang, Guiming, et al.
Publicado: (2018)

Sonographic assessment of extent and aggressiveness of malignant breast disease
por: Stavros, T
Publicado: (2004)

Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
por: Locasale, Jason W, et al.
Publicado: (2012)

Autoregulation of H(+)/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production
por: Blaszczak, Wiktoria, et al.
Publicado: (2022)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
por: Johnson, Jennifer M., et al.
Publicado: (2017)

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
por: Ambrosetti, Damien, et al.
Publicado: (2018)

Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2021)

The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas
por: Jang, Se Min, et al.
Publicado: (2012)

Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer
por: Valença, Isabel, et al.
Publicado: (2015)

MCT4 Promotes Tumor Malignancy in F98 Glioma Cells
por: Reuss, Anna Maria, et al.
Publicado: (2021)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Inositol Phosphate Recycling Regulates Glycolytic and Lipid Metabolism That Drives Cancer Aggressiveness
por: Benjamin, Daniel I., et al.
Publicado: (2014)

The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
por: Reuss, Anna Maria, et al.
Publicado: (2021)

Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance
por: Li, Na, et al.
Publicado: (2020)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

Ectodermal dysplasia: aggressive treatment of oligodontia versus non-intervention?
por: Kurtz, KS
Publicado: (2012)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

Recommendations of Swiss users to reduce aggression and coercive measures in psychiatric wards
por: Abderhalden, Christoph, et al.
Publicado: (2007)

Advances in the study of aerobic glycolytic effects in resistance to radiotherapy in malignant tumors
por: Liu, Yuyi, et al.
Publicado: (2023)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

Marked Seizure Reduction after MCT Supplementation
por: Azzam, Raed, et al.
Publicado: (2013)

The glycolytic enzyme phosphofructokinase-1 assembles into filaments
por: Webb, Bradley A., et al.
Publicado: (2017)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017)

Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018)

Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
por: Liu, Tian, et al.
Publicado: (2023)

Can aggressive postoperative non-narcotic therapy replace narcotics in patients undergoing laparoscopic hysterectomies?
por: Singh, G, et al.
Publicado: (2015)

Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma
por: Thakur, A., et al.
Publicado: (2020)

Saphenous vein graft interposition following aggressive endarterectomy for right coronary artery: experience with 32 cases
por: Besir, Y, et al.
Publicado: (2013)

OA17 An evolving case of Anti PM/Scl Anti body associated Aggressive Systemic Sclerosis
por: Subasinghe, Sunari, et al.
Publicado: (2022)

The importance of helplines in National Plans
por: Mazzucato, Monica, et al.
Publicado: (2014)

Intranasal delivery of Thyroid hormones in MCT8 deficiency
por: Grijota-Martínez, Carmen, et al.
Publicado: (2020)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pbl7hn9ptg1kp846e6talpp38o